Yale Only

Developmental Therapeutics Research Seminar: “Single Arm Neoadjuvant Phase I/II Study of MEDI4736 (anti-PD-L1 antibody) Concomitant with Weekly Nab-paclitaxel and Dose-dense Doxorubicin/cyclophosphamide (ddAC) Chemotherapy for Clinical Stage I-III Triple Negative Breast Cancer (TNBC)”

Name: Developmental Therapeutics Research Seminar: “Single Arm Neoadjuvant Phase I/II Study of MEDI4736 (anti-PD-L1 antibody) Concomitant with Weekly Nab-paclitaxel and Dose-dense Doxorubicin/cyclophosphamide (ddAC) Chemotherapy for Clinical Stage I-III Triple Negative Breast Cancer (TNBC)”
Start: 2020-05-15T17:00:00.0000000Z
End: 2020-05-15T18:00:00.0000000Z
Location: Yale University

https://zoom.us/j/92493750511

Add event to Calendar

Speaker

Kim Blenman, PhD, MS
Assistant Professor of Medicine (Medical Oncology) and Assistant Professor of Computer Science

Hosts

Karen Anderson, PhD

203.785.4526

karen.anderson@yale.edu

Barbara Burtness, MD

203.737.7636

barbara.burtness@yale.edu

Admission

Free

Tag

Lectures and Seminars